• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Self-reported fever, treatment actions and malaria infection prevalence in the northern states of Sudan.苏丹北部各州的自我报告发热、治疗措施和疟疾感染流行情况。
Malar J. 2011 May 15;10:128. doi: 10.1186/1475-2875-10-128.
2
Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa, 2003-2015: a modelling study using data from national surveys.2003-2015 年非洲 5 岁以下发热合并恶性疟原虫感染儿童青蒿素为基础的联合治疗覆盖率:基于国家调查数据的建模研究。
Lancet Glob Health. 2017 Apr;5(4):e418-e427. doi: 10.1016/S2214-109X(17)30076-1.
3
Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study.在固定卫生机构常规提供青蒿素复方疗法可降低坦桑尼亚的疟疾发病率:一项观察性研究。
Malar J. 2012 Apr 30;11:140. doi: 10.1186/1475-2875-11-140.
4
Assessment of submicroscopic infections and gametocyte carriage of Plasmodium falciparum during peak malaria transmission season in a community-based cross-sectional survey in western Kenya, 2012.2012年在肯尼亚西部开展的一项基于社区的横断面调查中,对疟疾传播高峰期恶性疟原虫的亚显微感染和配子体携带情况进行评估。
Malar J. 2016 Aug 19;15(1):421. doi: 10.1186/s12936-016-1482-4.
5
Description of Plasmodium falciparum infections in central Gabon demonstrating high parasite densities among symptomatic adolescents and adults.描述加蓬中部的恶性疟原虫感染情况,表明症状性青少年和成年人中的寄生虫密度很高。
Malar J. 2019 Nov 21;18(1):371. doi: 10.1186/s12936-019-3002-9.
6
History of malaria treatment as a predictor of subsequent subclinical parasitaemia: a cross-sectional survey and malaria case records from three villages in Pailin, western Cambodia.疟疾治疗史作为后续亚临床寄生虫血症预测指标的研究:柬埔寨西部拜林三个村庄的横断面调查及疟疾病例记录
Malar J. 2016 Apr 26;15:240. doi: 10.1186/s12936-016-1284-8.
7
The relationship between reported fever and Plasmodium falciparum infection in African children.报告发热与非洲儿童中恶性疟原虫感染的关系。
Malar J. 2010 Apr 19;9:99. doi: 10.1186/1475-2875-9-99.
8
Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.在坦桑尼亚,给蒿甲醚-本芴醇添加单剂量低剂量伯氨喹(0.25毫克/千克)不会影响单纯性恶性疟原虫疟疾的治疗效果:一项随机、单盲临床试验。
Malar J. 2016 Aug 26;15(1):435. doi: 10.1186/s12936-016-1430-3.
9
Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.瓦努阿图共和国的活动性病例检测、采用氯喹和磺胺多辛/乙胺嘧啶联合治疗恶性疟和氯喹治疗间日疟以及抗疟药物耐药性的分子标记物。
Malar J. 2010 Apr 6;9:89. doi: 10.1186/1475-2875-9-89.
10
Efficacies of DHA-PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan.在苏丹季节性传播不稳定地区,DHA-PPQ和蒿甲醚/苯芴醇对单纯性恶性疟患者的疗效。
Malar J. 2017 Apr 20;16(1):163. doi: 10.1186/s12936-017-1817-9.

引用本文的文献

1
Factors contributing to mosquito-borne disease: A systematic review in the Middle East and North Africa (MENA) region.导致蚊媒疾病的因素:中东和北非(MENA)地区的系统评价
Curr Res Parasitol Vector Borne Dis. 2025 Jun 17;8:100281. doi: 10.1016/j.crpvbd.2025.100281. eCollection 2025.
2
Improving socioeconomic status may reduce the burden of malaria in sub Saharan Africa: A systematic review and meta-analysis.提高社会经济地位可能会减轻撒哈拉以南非洲地区的疟疾负担:系统评价和荟萃分析。
PLoS One. 2019 Jan 24;14(1):e0211205. doi: 10.1371/journal.pone.0211205. eCollection 2019.
3
Advances in mapping malaria for elimination: fine resolution modelling of Plasmodium falciparum incidence.消除疟疾的进展:恶性疟原虫发病率的精细分辨率建模。
Sci Rep. 2016 Jul 13;6:29628. doi: 10.1038/srep29628.
4
Use of Antimalarial in the Management of Fever during a Community Survey in the Kintampo Districts of Ghana.在加纳金坦波地区社区调查期间抗疟药在发热管理中的应用
PLoS One. 2015 Nov 18;10(11):e0142106. doi: 10.1371/journal.pone.0142106. eCollection 2015.
5
Factors Associated with Testing and Prompt Use of Recommended Antimalarials following Malaria Diagnosis: A Secondary Analysis of 2011-12 Tanzania HIV and Malaria Indicator Survey Data.疟疾诊断后与检测及及时使用推荐抗疟药相关的因素:对2011 - 12年坦桑尼亚艾滋病毒与疟疾指标调查数据的二次分析
PLoS One. 2015 Jul 17;10(7):e0132964. doi: 10.1371/journal.pone.0132964. eCollection 2015.
6
Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance.在引入以青蒿素为基础的联合疗法八年后苏丹的抗疟药物处方实践及其对耐药性发展的影响。
BMC Pharmacol Toxicol. 2015 Mar 26;16:3. doi: 10.1186/s40360-015-0002-4.
7
Symptomatic malaria diagnosis overestimate malaria prevalence, but underestimate anaemia burdens in children: results of a follow up study in Kenya.有症状疟疾诊断高估了疟疾流行率,但低估了儿童贫血负担:肯尼亚一项随访研究的结果
BMC Public Health. 2014 Apr 9;14:332. doi: 10.1186/1471-2458-14-332.
8
Spatial modelling of healthcare utilisation for treatment of fever in Namibia.纳米比亚发热治疗医疗利用的空间建模。
Int J Health Geogr. 2012 Feb 15;11:6. doi: 10.1186/1476-072X-11-6.
9
Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine.来自接受青蒿琥酯-咯萘啶治疗的苏丹疟疾病人的疟原虫 Pfmdr1 拷贝数增加和序列多态性。
Antimicrob Agents Chemother. 2011 Nov;55(11):5408-11. doi: 10.1128/AAC.05102-11. Epub 2011 Sep 6.

本文引用的文献

1
Reduction in the proportion of fevers associated with Plasmodium falciparum parasitaemia in Africa: a systematic review.非洲疟疾寄生虫血症相关发热比例降低:系统评价。
Malar J. 2010 Aug 22;9:240. doi: 10.1186/1475-2875-9-240.
2
The international limits and population at risk of Plasmodium vivax transmission in 2009.2009 年按蚊传播间日疟原虫的国际界限和危险人群。
PLoS Negl Trop Dis. 2010 Aug 3;4(8):e774. doi: 10.1371/journal.pntd.0000774.
3
Estimating the number of paediatric fevers associated with malaria infection presenting to Africa's public health sector in 2007.估算 2007 年非洲公立卫生部门因疟疾感染而就诊的儿科发热病例数。
PLoS Med. 2010 Jul 6;7(7):e1000301. doi: 10.1371/journal.pmed.1000301.
4
Malaria in Africa: progress and prospects in the decade since the Abuja Declaration.非洲的疟疾:自《阿布贾宣言》发布以来十年的进展与前景
Lancet. 2010 Jul 10;376(9735):137-9. doi: 10.1016/S0140-6736(10)60577-6. Epub 2010 Apr 22.
5
The relationship between reported fever and Plasmodium falciparum infection in African children.报告发热与非洲儿童中恶性疟原虫感染的关系。
Malar J. 2010 Apr 19;9:99. doi: 10.1186/1475-2875-9-99.
6
Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis.恶性疟原虫流行地区的亚显微感染:一项系统评价与荟萃分析。
J Infect Dis. 2009 Nov 15;200(10):1509-17. doi: 10.1086/644781.
7
Malaria preventive measures, health care seeking behaviour and malaria burden in different epidemiological settings in Sudan.在苏丹不同流行病学环境下的疟疾预防措施、卫生保健寻求行为和疟疾负担。
Trop Med Int Health. 2009 Dec;14(12):1488-95. doi: 10.1111/j.1365-3156.2009.02394.x. Epub 2009 Sep 24.
8
Antimalarial prescribing and dispensing practices in health centres of Khartoum state, 2003-04.2003 - 2004年喀土穆州各保健中心的抗疟药物处方与配药情况
East Mediterr Health J. 2009 Jan-Feb;15(1):122-8.
9
A world malaria map: Plasmodium falciparum endemicity in 2007.一幅世界疟疾地图:2007年恶性疟原虫的流行情况
PLoS Med. 2009 Mar 24;6(3):e1000048. doi: 10.1371/journal.pmed.1000048.
10
Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan's conditions using artemisinin-based combination therapy and rapid diagnostic test.采用青蒿素联合疗法和快速诊断检测,根据苏丹国情调整的疟疾家庭管理策略的可行性和可接受性。
Malar J. 2009 Mar 9;8:39. doi: 10.1186/1475-2875-8-39.

苏丹北部各州的自我报告发热、治疗措施和疟疾感染流行情况。

Self-reported fever, treatment actions and malaria infection prevalence in the northern states of Sudan.

机构信息

National Malaria Control Programme, Federal Ministry of Health, PO Box 1204 Khartoum, Sudan.

出版信息

Malar J. 2011 May 15;10:128. doi: 10.1186/1475-2875-10-128.

DOI:10.1186/1475-2875-10-128
PMID:21575152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3115918/
Abstract

BACKGROUND

The epidemiology of fevers and their management in areas of low malaria transmission in Africa is not well understood. The characteristics of fever, its treatment and association with infection prevalence from a national household sample survey in the northern states of Sudan, an area that represents historically low parasite prevalence, are examined in this study.

METHODS

In October-November 2009, a cluster sample cross-sectional household malaria indicator survey was undertaken in the 15 northern states of the Sudan. Data on household assets and individual level information on age, sex, whether the individual had a fever in the last 14 days and on the day of survey, actions taken to treat the fever including diagnostic services and drugs used and their sources were collected. Consenting household members were asked to provide a finger-prick blood sample and examined for malaria parasitaemia using a rapid diagnostic test (RDT). All proportions and odds ratios were weighted and adjusted for clustering.

RESULTS

Of 26,471 respondents 19% (n = 5,299) reported a history of fever within the last two weeks prior to the survey and 8% had fever on the day of the survey. Only 39% (n = 2,035) of individuals with fever in last two weeks took any action, of which 43% (n = 875) were treated with anti-malarials. About 44% (n = 382) of malaria treatments were done using the nationally recommended first-line therapy artesunate+sulphadoxine-pryrimethamine (AS+SP) and 13% (n = 122) with non-recommended chloroquine or SP. Importantly 33.9% (n = 296) of all malaria treatments included artemether monotherapy, which is internationally banned for the treatment of uncomplicated malaria. About 53% of fevers had some form of parasitological diagnosis before treatment. On the day of survey, 21,988 individuals provided a finger-prick blood sample and only 1.8% were found positive for Plasmodium falciparum. Infection prevalence was higher among individuals who had fever in the last two weeks (OR = 3.4; 95%CI = 2.6 - 4.4, p < 0.001) or reported fever on the day of survey (OR = 6.2; 95%CI = 4.4 - 8.7, p < 0.001) compared to those without a history of fever.

CONCLUSION

Across the northern states of the Sudan, the period prevalence of fever is low. The proportion of fevers that are likely to be malaria is very low. Consequently, parasitological diagnosis of all fevers before treatment is an appropriate strategy for malaria case-management. Improved regulation and supervision of health workers is required to increase the use of diagnostics and remove the practice of prescribing artemisinin monotherapy.

摘要

背景

在疟疾传播水平较低的非洲地区,发热的流行病学特征及其处理方法尚不清楚。本研究旨在探讨苏丹北部各州(历史上寄生虫感染率较低的地区)全国家庭抽样调查中发热的特征、治疗方法及其与感染率的关系。

方法

2009 年 10 月至 11 月,在苏丹北部 15 个州开展了疟疾指示性家庭横断面抽样调查。收集了家庭资产和个人层面的信息,包括年龄、性别、过去 14 天内是否发热、调查当天是否发热、发热时采取的治疗措施(包括诊断服务和使用的药物以及来源)。同意的家庭成员被要求提供指血样,并使用快速诊断检测(RDT)进行疟疾寄生虫检测。所有比例和比值比均经过加权处理,并根据聚类进行了调整。

结果

在 26471 名受访者中,19%(n=5299)报告在调查前两周内有发热史,8%(n=1529)在调查当天发热。仅有 39%(n=2035)的发热患者采取了任何治疗措施,其中 43%(n=875)接受了抗疟药物治疗。大约 44%(n=382)的疟疾治疗采用了国家推荐的一线治疗药物青蒿琥酯+磺胺多辛-乙胺嘧啶(AS+SP),13%(n=122)采用了非推荐药物氯喹或磺胺多辛。重要的是,33.9%(n=296)的所有疟疾治疗均包含青蒿素单药疗法,而国际上已禁止将青蒿素单药疗法用于治疗无并发症的疟疾。在治疗前,约 53%的发热患者进行了某种形式的寄生虫学诊断。在调查当天,21988 人提供了指血样,仅发现 1.8%的人感染恶性疟原虫。与无发热史者相比,在过去两周内有发热史(OR=3.4;95%CI=2.6-4.4,p<0.001)或报告当天发热(OR=6.2;95%CI=4.4-8.7,p<0.001)的个体中,发热的感染率更高。

结论

在苏丹北部各州,发热的流行率较低。发热中可能为疟疾的比例非常低。因此,在治疗前对所有发热患者进行寄生虫学诊断是疟疾病例管理的一项适当策略。需要加强对卫生工作者的监管和规范,以增加诊断服务的使用,并消除开具青蒿素单药疗法的做法。